lansoprazole and ponatinib

lansoprazole has been researched along with ponatinib in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF	1
Davis, J; Dorer, DJ; Narasimhan, NI; Sonnichsen, D; Turner, CD	1

Reviews

1 review(s) available for lansoprazole and ponatinib

Article	Year
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators. European journal of medicinal chemistry, 2022, Jul-05, Volume: 237 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells	2022

Trials

1 trial(s) available for lansoprazole and ponatinib

Article	Year
Evaluation of the effect of multiple doses of lansoprazole on the pharmacokinetics and safety of ponatinib in healthy subjects. Clinical drug investigation, 2014, Volume: 34, Issue:10 Topics: Adult; Area Under Curve; Cross-Over Studies; Drug Interactions; Female; Humans; Hydrogen-Ion Concentration; Imidazoles; Lansoprazole; Male; Middle Aged; Protein Kinase Inhibitors; Proton Pump Inhibitors; Pyridazines; Solubility	2014

Article

Year

Evaluation of the effect of multiple doses of lansoprazole on the pharmacokinetics and safety of ponatinib in healthy subjects.

Clinical drug investigation, 2014, Volume: 34, Issue:10

Topics: Adult; Area Under Curve; Cross-Over Studies; Drug Interactions; Female; Humans; Hydrogen-Ion Concentration; Imidazoles; Lansoprazole; Male; Middle Aged; Protein Kinase Inhibitors; Proton Pump Inhibitors; Pyridazines; Solubility

2014